Pancreatic Ductal Adenocarcinoma Pipeline Insights 2016 - Research and Markets

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/z8wf3d/pancreatic_ductal) has announced the addition of the "Pancreatic Ductal Adenocarcinoma-Pipeline Insights, 2016" report to their offering.

Pancreatic Ductal Adenocarcinoma-Pipeline Insights 2016 provides in depth insight on the pipeline drugs and their development activities around the Pancreatic Ductal Adenocarcinoma.

The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. The Report covers the product clinical trials information and other development activities including technology, licensing, collaboration, acquisitions, funding, patent and USFDA & EMA designations details.

The Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Pancreatic Ductal Adenocarcinoma. The report also assesses the Pancreatic Ductal Adenocarcinoma therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Key Topics Covered:

  1. Pancreatic Ductal Adenocarcinoma Overview
  2. Pancreatic Ductal Adenocarcinoma Pipeline Therapeutics
  3. Pancreatic Ductal Adenocarcinoma Therapeutics under Development by Companies
  4. Pancreatic Ductal Adenocarcinoma Filed and Phase III Products
  5. Comparative Analysis
  6. Pancreatic Ductal Adenocarcinoma Phase II Products
  7. Comparative Analysis
  8. Pancreatic Ductal Adenocarcinoma Phase I and IND Filed Products
  9. Comparative Analysis
  10. Pancreatic Ductal Adenocarcinoma Discovery and Pre-Clinical Stage Products
  11. Comparative Analysis
  12. Drug Candidate Profiles
  13. Pancreatic Ductal Adenocarcinoma - Therapeutics Assessment
  14. Assessment by Monotherapy Products
  15. Assessment by Combination Products
  16. Assessment by Route of Administration
  17. Assessment by Molecule Type
  18. Pancreatic Ductal Adenocarcinoma - Discontinued Products
  19. Pancreatic Ductal Adenocarcinoma - Dormant Products
  20. Companies Involved in Therapeutics Development for Pancreatic Ductal Adenocarcinoma

For more information visit http://www.researchandmarkets.com/research/z8wf3d/pancreatic_ductal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals